Direct Biologics, Good Works II Sign Potential $1B SPAC Deal
Late-stage biotech company Direct Biologics LLC and special-purpose acquisition company Good Works II Acquisition Corp. said Thursday they signed a definitive agreement to launch a new public company, which could reach...To view the full article, register now.
Already a subscriber? Click here to view full article